Anavex Life Sciences Corp.
AVXLNasdaqCIK 1314052HealthcareFiscal year ends Sep 30
Income statement
| Line item | Unit | Q4 FY20232023-09-30 | Q1 FY20242023-12-31 | Q2 FY20242024-03-31 | Q3 FY20242024-06-30 | Q4 FY20242024-09-30 | Q1 FY20252024-12-31 | Q2 FY20252025-03-31 | Q3 FY20252025-06-30 | Q4 FY20252025-09-30 | Q1 FY20262025-12-31 | Q2 FY20262026-03-31 | Q3 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $m | 10.1Research and development, Q4 FY2023, three months to 2023-09-30$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | 8.7Research and development, Q1 FY2024, three months to 2023-12-31$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | 9.7Research and development, Q2 FY2024, three months to 2024-03-31$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | 11.8Research and development, Q3 FY2024, three months to 2024-06-30$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 11.6Research and development, Q4 FY2024, three months to 2024-09-30$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | 10.4Research and development, Q1 FY2025, three months to 2024-12-31$10.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 9.9Research and development, Q2 FY2025, three months to 2025-03-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 10.0Research and development, Q3 FY2025, three months to 2025-06-30$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 7.3Research and development, Q4 FY2025, three months to 2025-09-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | 4.7Research and development, Q1 FY2026, three months to 2025-12-31$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 4.2Research and development, Q2 FY2026, three months to 2026-03-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | 3.1Selling, general and administrative, Q1 FY2025, three months to 2024-12-31$3.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 2.6Selling, general and administrative, Q2 FY2025, three months to 2025-03-31$2.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 4.5Selling, general and administrative, Q3 FY2025, three months to 2025-06-30$4.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 3.6Selling, general and administrative, Q4 FY2025, three months to 2025-09-30$3.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | 2.1Selling, general and administrative, Q1 FY2026, three months to 2025-12-31$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 2.3Selling, general and administrative, Q2 FY2026, three months to 2026-03-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 2.0Selling, general and administrative, Q3 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Operating income | $m | (12.7)Operating income, Q4 FY2023, three months to 2023-09-30−$12.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (11.4)Operating income, Q1 FY2024, three months to 2023-12-31−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | (12.6)Operating income, Q2 FY2024, three months to 2024-03-31−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | (14.6)Operating income, Q3 FY2024, three months to 2024-06-30−$14.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | (14.3)Operating income, Q4 FY2024, three months to 2024-09-30−$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (13.6)Operating income, Q1 FY2025, three months to 2024-12-31−$13.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (12.5)Operating income, Q2 FY2025, three months to 2025-03-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | (14.5)Operating income, Q3 FY2025, three months to 2025-06-30−$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | (10.8)Operating income, Q4 FY2025, three months to 2025-09-30−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (6.8)Operating income, Q1 FY2026, three months to 2025-12-31−$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (6.5)Operating income, Q2 FY2026, three months to 2026-03-31−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 6.7Operating income, Q3 FY2026, three months to 2026-06-30$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | 0.0Income tax, Q1 FY2026, three months to 2025-12-31$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 0.0Income tax, Q2 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-28, accession 0001731122-26-001166. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Income tax, Q3 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-28, accession 0001731122-26-001167. Derived: 9-month figure less the 6-month figure.Report this figure |
| Net income | $m | (10.1)Net income, Q4 FY2023, three months to 2023-09-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (8.6)Net income, Q1 FY2024, three months to 2023-12-31−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | (10.5)Net income, Q2 FY2024, three months to 2024-03-31−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | (12.2)Net income, Q3 FY2024, three months to 2024-06-30−$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | (11.6)Net income, Q4 FY2024, three months to 2024-09-30−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (12.1)Net income, Q1 FY2025, three months to 2024-12-31−$12.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (11.2)Net income, Q2 FY2025, three months to 2025-03-31−$11.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | (13.2)Net income, Q3 FY2025, three months to 2025-06-30−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | (9.8)Net income, Q4 FY2025, three months to 2025-09-30−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (5.7)Net income, Q1 FY2026, three months to 2025-12-31−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (5.3)Net income, Q2 FY2026, three months to 2026-03-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 7.8Net income, Q3 FY2026, three months to 2026-06-30$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Diluted EPS | $ per share | not reported | (0.11)Diluted EPS, Q1 FY2024, three months to 2023-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | (0.13)Diluted EPS, Q2 FY2024, three months to 2024-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | (0.14)Diluted EPS, Q3 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | not reported | (0.14)Diluted EPS, Q1 FY2025, three months to 2024-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (0.13)Diluted EPS, Q2 FY2025, three months to 2025-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | (0.16)Diluted EPS, Q3 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | not reported | (0.06)Diluted EPS, Q1 FY2026, three months to 2025-12-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (0.06)Diluted EPS, Q2 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 0.08Diluted EPS, Q3 FY2026, three months to 2026-06-30$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Basic EPS | $ per share | not reported | (0.11)Basic EPS, Q1 FY2024, three months to 2023-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | (0.13)Basic EPS, Q2 FY2024, three months to 2024-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | (0.14)Basic EPS, Q3 FY2024, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | not reported | (0.14)Basic EPS, Q1 FY2025, three months to 2024-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (0.13)Basic EPS, Q2 FY2025, three months to 2025-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | (0.16)Basic EPS, Q3 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | not reported | (0.06)Basic EPS, Q1 FY2026, three months to 2025-12-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (0.06)Basic EPS, Q2 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 0.08Basic EPS, Q3 FY2026, three months to 2026-06-30$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
Balance sheet
| Line item | Unit | FY20232023-09-30 | Q1 FY20242023-12-31 | Q2 FY20242024-03-31 | Q3 FY20242024-06-30 | FY20242024-09-30 | Q1 FY20252024-12-31 | Q2 FY20252025-03-31 | Q3 FY20252025-06-30 | FY20252025-09-30 | Q1 FY20262025-12-31 | Q2 FY20262026-03-31 | Q3 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 151Cash and equivalents, FY2023, at 2023-09-30$151.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-12-23, accession 0001731122-24-002041.Report this figure | 144Cash and equivalents, Q1 FY2024, at 2023-12-31$143.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-07, accession 0001731122-24-000206.Report this figure | 139Cash and equivalents, Q2 FY2024, at 2024-03-31$139.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001731122-24-000760.Report this figure | 139Cash and equivalents, Q3 FY2024, at 2024-06-30$138.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001731122-24-001207.Report this figure | 132Cash and equivalents, FY2024, at 2024-09-30$132.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2026-08-28, accession 0001731122-26-001164.Report this figure | 121Cash and equivalents, Q1 FY2025, at 2024-12-31$120.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | 116Cash and equivalents, Q2 FY2025, at 2025-03-31$115.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | 101Cash and equivalents, Q3 FY2025, at 2025-06-30$101.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 103Cash and equivalents, FY2025, at 2025-09-30$102.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 132Cash and equivalents, Q1 FY2026, at 2025-12-31$131.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 127Cash and equivalents, Q2 FY2026, at 2026-03-31$127.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 118Cash and equivalents, Q3 FY2026, at 2026-06-30$118.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | 154Total assets, FY2023, at 2023-09-30$154.4m. XBRL concept us-gaap:Assets. 10-K filed 2024-12-23, accession 0001731122-24-002041.Report this figure | 148Total assets, Q1 FY2024, at 2023-12-31$148.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-07, accession 0001731122-24-000206.Report this figure | 145Total assets, Q2 FY2024, at 2024-03-31$144.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001731122-24-000760.Report this figure | 142Total assets, Q3 FY2024, at 2024-06-30$141.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001731122-24-001207.Report this figure | 136Total assets, FY2024, at 2024-09-30$135.6m. XBRL concept us-gaap:Assets. 10-K/A filed 2026-08-28, accession 0001731122-26-001164.Report this figure | 124Total assets, Q1 FY2025, at 2024-12-31$124.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | 117Total assets, Q2 FY2025, at 2025-03-31$117.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | 102Total assets, Q3 FY2025, at 2025-06-30$102.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 104Total assets, FY2025, at 2025-09-30$103.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 133Total assets, Q1 FY2026, at 2025-12-31$133.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 129Total assets, Q2 FY2026, at 2026-03-31$128.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 120Total assets, Q3 FY2026, at 2026-06-30$120.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | 12.5Total liabilities, FY2023, at 2023-09-30$12.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-12-23, accession 0001731122-24-002041.Report this figure | 12.5Total liabilities, Q1 FY2024, at 2023-12-31$12.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-07, accession 0001731122-24-000206.Report this figure | 9.6Total liabilities, Q2 FY2024, at 2024-03-31$9.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001731122-24-000760.Report this figure | 11.8Total liabilities, Q3 FY2024, at 2024-06-30$11.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001731122-24-001207.Report this figure | 15.3Total liabilities, FY2024, at 2024-09-30$15.3m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2026-08-28, accession 0001731122-26-001164.Report this figure | 13.1Total liabilities, Q1 FY2025, at 2024-12-31$13.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | 17.4Total liabilities, Q2 FY2025, at 2025-03-31$17.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | 11.5Total liabilities, Q3 FY2025, at 2025-06-30$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 8.9Total liabilities, FY2025, at 2025-09-30$8.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 6.4Total liabilities, Q1 FY2026, at 2025-12-31$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | 7.1Total liabilities, Q2 FY2026, at 2026-03-31$7.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 7.7Total liabilities, Q3 FY2026, at 2026-06-30$7.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | 142Shareholders' equity, FY2023, at 2023-09-30$141.9m. XBRL concept us-gaap:StockholdersEquity. 10-K/A filed 2026-08-28, accession 0001731122-26-001164.Report this figure | 136Shareholders' equity, Q1 FY2024, at 2023-12-31$135.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-13, accession 0001731122-25-000724.Report this figure | 135Shareholders' equity, Q2 FY2024, at 2024-03-31$135.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 130Shareholders' equity, Q3 FY2024, at 2024-06-30$129.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001731122-25-001105.Report this figure | 120Shareholders' equity, FY2024, at 2024-09-30$120.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 111Shareholders' equity, Q1 FY2025, at 2024-12-31$110.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 99.8Shareholders' equity, Q2 FY2025, at 2025-03-31$99.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 91.0Shareholders' equity, Q3 FY2025, at 2025-06-30$91.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 94.9Shareholders' equity, FY2025, at 2025-09-30$94.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 127Shareholders' equity, Q1 FY2026, at 2025-12-31$126.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001166.Report this figure | 122Shareholders' equity, Q2 FY2026, at 2026-03-31$121.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure | 112Shareholders' equity, Q3 FY2026, at 2026-06-30$112.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-28, accession 0001731122-26-001167.Report this figure |
Cash flow
| Line item | Unit | Q4 FY20232023-09-30 | Q1 FY20242023-12-31 | Q2 FY20242024-03-31 | Q3 FY20242024-06-30 | Q4 FY20242024-09-30 | Q1 FY20252024-12-31 | Q2 FY20252025-03-31 | Q3 FY20252025-06-30 | Q4 FY20252025-09-30 | Q1 FY20262025-12-31 | Q2 FY20262026-03-31 | Q3 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (5.8)Operating cash flow, Q4 FY2023, three months to 2023-09-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (7.3)Operating cash flow, Q1 FY2024, three months to 2023-12-31−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-12, accession 0001731122-25-000205.Report this figure | (11.7)Operating cash flow, Q2 FY2024, three months to 2024-03-31−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001731122-25-000724. Derived: 6-month figure less the 3-month figure.Report this figure | (5.2)Operating cash flow, Q3 FY2024, three months to 2024-06-30−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001731122-25-001105. Derived: 9-month figure less the 6-month figure.Report this figure | (6.7)Operating cash flow, Q4 FY2024, three months to 2024-09-30−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (12.1)Operating cash flow, Q1 FY2025, three months to 2024-12-31−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (5.9)Operating cash flow, Q2 FY2025, three months to 2025-03-31−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-28, accession 0001731122-26-001166. Derived: 6-month figure less the 3-month figure.Report this figure | (12.5)Operating cash flow, Q3 FY2025, three months to 2025-06-30−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-28, accession 0001731122-26-001167. Derived: 9-month figure less the 6-month figure.Report this figure | (8.6)Operating cash flow, Q4 FY2025, three months to 2025-09-30−$8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2026-08-28, accession 0001731122-26-001164. Derived: 12-month figure less the 9-month figure.Report this figure | (7.2)Operating cash flow, Q1 FY2026, three months to 2025-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-09, accession 0001731122-26-000200.Report this figure | (4.4)Operating cash flow, Q2 FY2026, three months to 2026-03-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-28, accession 0001731122-26-001166. Derived: 6-month figure less the 3-month figure.Report this figure | (9.1)Operating cash flow, Q3 FY2026, three months to 2026-06-30−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-28, accession 0001731122-26-001167. Derived: 9-month figure less the 6-month figure.Report this figure |
Shares
| Line item | Unit | Q1 FY20232022-12-31 | Q2 FY20232023-03-31 | Q3 FY20232023-06-30 | Q1 FY20242023-12-31 | Q2 FY20242024-03-31 | Q3 FY20242024-06-30 | Q1 FY20252024-12-31 | Q2 FY20252025-03-31 | Q3 FY20252025-06-30 | Q1 FY20262025-12-31 | Q2 FY20262026-03-31 | Q3 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | bn shares | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 85.4 | 0.1 | 0.1 | 92.9 |
Shares outstanding: 92.70m at Aug 28, 2026, from the cover of the 10-Q filed Aug 28, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.